Sign in
4

Changes in Ownership

NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-036432

Chief Technology Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Russek-Blum Niva · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-26 Grant or award : show line 1 in the form +200,000 467,953 D
Loading xslF345X06/ownership.xml…